DHPS and malaria: Our aim is to measure parasite clearance and protection from infection (PCPI) conferred by malaria chemoprevention over a 63-day period in the presence/absence of the dhps I431V mutation among healthy and symptom-free children between 3 and 5 years of age with unknown parasite status.